Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
18.80
-0.42 (-2.19%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $6.17 billion as of April 25, 2025. Its market cap has increased by 127.32% in one year.
Market Cap
6.17B
Enterprise Value
6.09B
1-Year Change
127.32%
Ranking
Category
Stock Price
18.80
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $6.17B, an increase of 5,254.70%. That is a compound annual growth rate of 70.70%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 744.81B |
| UnitedHealth Group | 389.54B |
| Johnson & Johnson | 374.44B |
| AbbVie | 313.20B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.18B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |